Resumen
Aims To examine the association of connecting peptide (C-peptide) and the risks of postpartum diabetes and pre-diabetes among women with prior gestational diabetes. Methods A cross-sectional study of 1263 women with prior gestational diabetes was carried out at 1–5 years after delivery in Tianjin, China. Logistic regression was used to assess the associations of C-peptide and the risks of diabetes and pre-diabetes. Results The multivariable-adjusted odds ratios based on different levels of C-peptide (0–33%, 34–66%, 67–90%, and > 90% as C-peptide cutpoints) were 1.00, 1.93 (95% confidence interval [CI] 0.85–4.39), 2.49 (95% CI 1.06–5.87), and 3.88 (95% CI 1.35–11.1) for diabetes (P for trend < 0.0001), and 1.00, 1.66 (95% CI 1.18–2.36), 2.38 (95% CI 1.56–3.62) and 2.35 (95% CI 1.27–4.37) for pre-diabetes (P for trend < 0.0001), respectively. Restricted cubic splines models showed a positive linear association of C-peptide as a continuous variable with the risks of type 2 diabetes and pre-diabetes. The positive association was significant when stratified by healthy weight and overweight participants. Conclusions We found a positive association between serum C-peptide levels and the risks of diabetes and pre-diabetes among Chinese women with prior gestational diabetes. Our finding suggested that elevated C-peptide levels may be a predictor of diabetes and pre-diabetes.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 1658-1662 |
Número de páginas | 5 |
Publicación | Journal of Diabetes and its Complications |
Volumen | 31 |
N.º | 12 |
DOI | |
Estado | Published - dic. 2017 |
Nota bibliográfica
Funding Information:This work was supported by the grant from European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly programme for Collaborative Research between China and Europe, Tianjin Women's and Children's Health Center, and Tianjin Public Health Bureau. Dr. Hu was supported by grant from National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R01DK100790 . We would also like to appreciate all families for participating in the Tianjin Gestational Diabetes Mellitus Prevention Program.
Funding Information:
This work was supported by the grant from European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly programme for Collaborative Research between China and Europe, Tianjin Women's and Children's Health Center, and Tianjin Public Health Bureau. Dr. Hu was supported by grant from National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R01DK100790. We would also like to appreciate all families for participating in the Tianjin Gestational Diabetes Mellitus Prevention Program.
Publisher Copyright:
© 2017 Elsevier Inc.
ASJC Scopus Subject Areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology